Before he became an instantly recognizable celebrity on the reality television program Survivor Africa, Ethan Zohn played soccer professionally for teams in both the United States and Zimbabwe. So when he won the competition and found himself $1 million richer, he had to make some decisions. What would he do with the money and his new celebrity?
It didn’t take long to decide. He decided to use his money and notoriety to help spread HIV and AIDS prevention education to young people in Africa. It fit Ethan’s character. It was the perfect way to blend his value of serving others while paying tribute to Africa – a continent of people who had taught him a great deal. Using professional soccer players, Ethan’s non-profit, Grassroot Soccer, is educating an entire generation of young Africans. Ethan is the national spokesperson for America Scores, an organization that helps inner city kids participate in educational soccer programs.
And that probably would have been the end of an admirable story – young, attractive soccer player puts his money to work for others. For several years, Ethan devoted himself to his non-profit and existed as a television celebrity. In 2009, Ethan was diagnosed with a rare form of Hodgkin’s Lymphoma. Suddenly he was fighting to become a “survivor” in a whole new sense. While he endured the rigors of cancer treatment, he became a national spokesperson for Katie Couric’s Stand Up to Cancer organization and kept a weekly video blog on People Magazine’s website. Millions watched Ethan fight the highs and lows of aggressive cancer treatment. His interest in service remained stronger than ever.
In recognition for his charitable work, Ethan has been awarded the “Nikosi Johnson Community Spirit Award” by the International Association of Physicians in AIDS Care, the “Heroes Among Us Award” from the Boston Celtics and the Massachusetts State Health Department and the Auxilia Chimusoro Award from the US State Department in Zimbabwe. In addition, he was awarded the 2007 Peace Abby “Courage of Conscience”, the 2008 Caring Hand’s “Philanthropic Achievement Award” and was named one of People Magazine’s “Helpers of the Year” in 2005.
Michael J. Wargovich, Ph.D.
Michael J. Wargovich, Ph.D., F.A.C.N.
Professor of Molecular Medicine
CTRC Council Distinguished Chair in Oncology
CTRC and UTHSCSA
A native of Pittsburgh, Pa., Dr. Wargovich received a B.A. at Washington and Jefferson College in biology and a M.S. from Duquesne University in Biological Sciences. He received a Ph.D. in microbiology from Texas Tech University in 1981. He then undertook post-doctoral studies at the Ontario Cancer Institute and Ludwig Institute for Cancer Research in Toronto, Canada. There, Dr. Wargovich first began research in the emerging discipline of cancer chemoprevention.
Recruited to the world-renowned MD Anderson Cancer Center in Houston in 1984, Dr. Wargovich pioneered the development of preventive agents. Dr. Wargovich studied hundreds of agents for cancer prevention activity. Among the discoveries made were the cancer preventive roles for compounds in green and black tea, various herbal and alternative medicine products, citrus, and cruciferous vegetables.
In 2012, he relocated to The University of Texas Health Science Center at San Antonio where he co-leads the Cancer Prevention and Population Science Program for the NCI-designated Cancer Therapy & Research Center. He holds the CTRC Council Distinguished Chair in Oncology. Research in his laboratory focuses on the prevention of colon cancer. Dr. Wargovich's research involves studying the effects green tea and antioxidant compounds have upon tumor growth.
Dr. Wargovich is an international expert in colon cancer, cancer chemoprevention and botanical medicine related to cancer.
Rowena N. Schwartz, Pharm.D., BCOP
Rowena N. Schwartz, Pharm.D., BCOP
Senior Director of Clinical Content and Services
McKesson Specialty Health
Rowena N. Schwartz is the Senior Director of Clinical Content and Services at McKesson Specialty Health.
Dr. Schwartz received a Bachelor of Science in Pharmacy at the College of Pharmacy, University of Illinois at the Medical Center in Chicago and a Doctor of Pharmacy at the University of Texas Health Science Center at San Antonio. She completed a two-year fellowship in oncology drug development at the University of Texas. Dr. Schwartz is a board certified oncology pharmacist.
During the course of her career she has practiced in a variety of oncology practice settings, and has been an Oncology Clinical Pharmacy Specialist in adult hematology, oncology and stem cell transplantation at the University of Pittsburgh Cancer Center. Additionally, she was the Director of Oncology Pharmacy at the Johns Hopkins Hospital where she continued an active clinical practice with the Johns Hopkins Hospital Oncology Anticoagulation Service.
Dr. Schwartz’s practice and research interest is in the area of drug therapy for the prevention and/or management of cancer and cancer related complications. She has a focused interest in geriatric oncology. Rowena is a an active member of the Hematology and Oncology Pharmacy Association, American Society of Health System Pharmacist, Geriatric Oncology Consortium, the International Society of Oncology Pharmacy and the Oncology Nursing Society. She has authored numerous chapters, journal articles and abstracts in various topics related to pharmacy practice in oncology, and speaks frequently on pharmacy and multidisciplinary aspects of oncology practice.